Failure to adhere to HIV treatment is costing lives The Ndovu Study is strengthening HIV treatment by redefining how treatment failure and drug resistance are detected, managed, and prevented across ...
On 14 July 2025, the World Health Organization (WHO) issued new guidelines recommending twice-yearly injectable lenacapavir as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention.